PMGC Holdings Inc. (ELAB) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$1.87

From 52W high−99.96%

Volume46791.00

Market cap$1.60M

P/E (TTM)—

P/S (TTM)2.7x

Div yield—

Key dataNov 4, 2026

Open

$1.87

From 52W high

−99.96%

Volume

46791.00

Market cap

$1.60M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.5x

P/E (TTM)

—

RSI (14)

17.7

MomentumView details →

1D Return

+2.06%

YTD Return

−99.86%

SummaryUpdated Jun 1, 2026

PMGC Holdings Inc. (NASDAQ:ELAB) is a biopharmaceutical company founded in 2020 and based in Newport Beach, California. The company was formerly known as Elevai Labs, Inc. before changing its name to PMGC Holdings Inc. in December 2024. PMGC went public in November 2023 and focuses on developing cutting-edge aesthetic medicines and therapeutic products, with particular emphasis on addressing obesity-related challenges through innovative probiotic approaches.

Ask drillr about PMGC Holdings Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.5x

EV/Sales

−5.5x

P/S (TTM)

2.7x

P/B (TTM)

0.1x

ProfitabilityView details →

Gross Margin

12.68%

Net Margin

−1306.28%

EBITDA Margin

−1231.39%

ROE (TTM)

−46.05%

ROA (TTM)

−21.08%

Asset Turnover

0.02x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−8.34%

EPS CAGR 3Y

+94.25%

EBITDA YoY

—

MomentumView details →

1D Return

+2.06%

YTD Return

−99.86%

1Y Return

−99.96%

RSI (14)

17.7

vs 50D SMA

−49.06%

vs 200D SMA

−94.12%

Capital & dividendView details →

Debt/Equity

0.83x

Current Ratio

1.36x

Quick Ratio

1.30x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.61

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.97M

Net Income (TTM)

−15.86M

Op. CF (TTM)

—

Latest newsMore news →

PMGC Holdings Inc. agreed to purchase US$1.845 million in secured debentures issued by Nuclea Energy Canada Inc.2d ago

PMGC Holdings completed a $100 million SPAC IPO for NorthStrive Acquisition Corp. I, which began trading on Nasdaq under the ticker NSAI.34d ago

Similar companies

YD Bio Limited WarrantsYDESW Hepion Pharmaceuticals, Inc.HEPA GeoVax Labs, Inc.GOVX Biodexa Pharmaceuticals PlcBDRX Moolec Science S.A.MLEC Virax Biolabs Group LimitedVRAX Find similar companies →

Latest newsMore news →

PMGC Holdings Inc. agreed to purchase US$1.845 million in secured debentures issued by Nuclea Energy Canada Inc.2d ago PMGC Holdings completed a $100 million SPAC IPO for NorthStrive Acquisition Corp. I, which began trading on Nasdaq under the ticker NSAI.34d ago